Hematology CME

Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Antibody Therapy in Acute Leukemia: Understanding Clinical Considerations for Use in Conjunction With HSCT
Professor David I. Marks
September 18, 2020
Credits: 1.00 CME
Penn State College of Medicine
Perspectives on Innovative Treatment for B-Cell Malignancies
John M. Pagel, MD, PhD
August 25, 2020
Credits: 0.50 CME / MOC / CPE
Medical Learning Institute, Inc.
Implementing Care With Extended Half-Life Factor VIII Therapy in Hemophilia A: An Interdisciplinary Conversation on Personalized Patient Management
Doris Quon, MD, PhD
August 25, 2020
Credits: 1.00 CME / CNE
University of Florida College of Medicine / Medical Learning Institute, Inc.
Ensuring the Rapid Recognition and Optimal Management of Hemophilia in the Emergency Department: The Role of Inclusive Decision-Making
Brandon R. Allen, MD, FACEP
August 18, 2020
Credits: 1.00 CNE
Medical Learning Institute, Inc.
Meeting the Many Challenges of AML: Oncology Nurse Tactics in an Era of Novel Therapies
Sara M. Tinsley, PhD, APRN, AOCN
August 6, 2020
Credits: 1.00 CME / MOC
Penn State College of Medicine
How I Think, How I Treat: Understanding Innovation in Multiple Myeloma—New Models for Attacking Disease Across the Clinical Spectrum
Sagar Lonial, MD, FACP
July 17, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
How I Think, How I Treat: BTK Inhibitors as a Centerpiece of Care for Hematologic Cancers
John C. Byrd, MD
July 16, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Following the Evidence to Effective Therapy for Myelofibrosis: How Clinicians Can Overcome Challenges in Patient Care in the JAK Inhibitor Era
Ruben A. Mesa, MD, FACP
July 14, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Transforming Modern Care in AML: Clinical Solutions With Novel Agents for Diverse Patient Populations
Harry P. Erba, MD, PhD
July 10, 2020
Credits: 1.00 CME / MOC / CPE
Medical Learning Institute, Inc.
Teaming Up to Reduce the Burden of Cancer-Associated VTE: Applying the Latest Guidelines and Evidence in Gastrointestinal and Hematologic Malignancies and Other Cancer Settings
Alok A. Khorana, MD, FACP, FASCO
July 2, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Taking a New Look at Cancer-Associated Venous Thromboembolism: How Is Emerging Evidence Influencing Guidelines & Practice?
Robert D. McBane, MD
June 30, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Transforming Care With BTK Inhibitors in CLL: New Insights on Therapy Selection, Safety, and Agent Sequencing Across the Treatment Continuum
Florence Cymbalista, MD, PhD
June 17, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Fueling Innovation in Multiple Myeloma: Thoughts From the Chair
Sagar Lonial, MD, FACP
June 16, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Advances in AML Care: Highlights From Recent Science
Harry P. Erba, MD, PhD
June 15, 2020
Credits: 0.50 CME / MOC / CPE
Medical Learning Institute, Inc.
Chair’s Take on Cancer-Associated VTE: Highlights From Recent Science
Alok A. Khorana, MD, FACP, FASCO
June 11, 2020
Credits: 0.75 CME
Medical Learning Institute, Inc.
Achieving Consensus on Modern VOD/SOS Management: A Guide to Disease Recognition, Classification, and Treatment in Adults and Pediatric Patients
Mitchell S. Cairo, MD
June 4, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficiency
Robin Lachmann, MD, PhD / Melissa Wasserstein, MD
June 3, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Purdue University
Biosimilars as Partners in Oncology: Expert Guidance on Understanding and Incorporating Biosimilar Agents in Real-World Care
Hope S. Rugo, MD, FASCO
April 28, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
Changing Perspectives on Multiple Myeloma and ASCT: Clinical Decision-Making, New Evidence, and Expanding Therapeutic Options
Sagar Lonial, MD, FACP
March 31, 2020
Credits: 1.00 CME / CNE / CPE
University of Florida College of Medicine
Making the Connection: A Call to Action Against Undiagnosed Atrial Fibrillation—Improving Detection, Reducing Risk
Christian T. Ruff, MD, MPH
March 27, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
State-of-the-Art Solutions for Myelofibrosis: The Intersection of JAK Inhibitors, Allogeneic Transplant, and Other Strategies for Patient Care
Prithviraj Bose, MD
March 23, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
Changing the Paradigm of CMV Management: New Science and More Choices for Challenging Cases in the HCT Setting
Roy F. Chemaly, MD, MPH, FIDSA, FACP
March 20, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
The Continuing Wave of Innovation in AML: Getting the Most From the Convergence of Novel Therapy and Allogeneic Transplant
Harry P. Erba, MD, PhD / James M. Foran, MD, FRCPC
March 13, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
Taking the Leap With CAR T: Opportunities for Improving Care and Optimizing Cell Therapy in Hematologic Cancers
Michael R. Bishop, MD
March 12, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
Following the Trail of Evidence in VOD Management: How Modern Risk Assessment, Diagnostic Principles, and Treatment Are Improving Care
Mitchell S. Cairo, MD
March 11, 2020
Credits: 2.00 CME
Penn State College of Medicine
Realizing the Promise of Novel Therapeutics in NHL: A MasterClass and Tumor Board on Clinical Decision-Making in FL, MCL, and DLBCL
John P. Leonard, MD
January 28, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Expanding Options for Prophylaxis and Treatment of Acute and Chronic GVHD: Mapping the Path to Better Patient Outcomes in Post-Transplant Care
Miguel-Angel Perales, MD
December 31, 2019
Credits: 1.50 CPE
Medical Learning Institute, Inc.
Exploring Emerging Strategies in the Management of Anemia in Chronic Kidney Disease
Jay B. Wish, MD
December 31, 2019
Credits: 2.00 CME
Medical Learning Institute, Inc.
How I Think, How I Treat: BTK Inhibitors as a Clinical Strategy in CLL, MCL, and Beyond—Therapeutic Selection, Sequencing, and Next Steps
Andre H. Goy, MD
December 30, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Recognizing and Managing Hemophilia in the Emergency Department in an Era of Expanding Therapeutic Options: A Progress-in-Practice MasterClass and Practicum
Sarah Luisa Melendez, MD / Doris Quon, MD, PhD
December 2, 2019

Pages